Earl F. Walborg
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment 7
- Molecular Biology top 10%
- Glycosylation and Glycoproteins Research 23
- RNA and protein synthesis mechanisms 5
- Pharmacology top 5%
- Biochemistry top 10%
-
- Microbial Metabolites in Food Biotechnology 6
-
- Carbohydrate Chemistry and Synthesis 6
-
- Toxin Mechanisms and Immunotoxins 5
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Enzyme Production and Characterization 3
Earl F. Walborg
60 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 321
- Molecular Biology 1.1k
- Pharmacology 125
- Biochemistry 82
- Health, Toxicology and Mutagenesis 181
Countries citing papers authored by Earl F. Walborg
This map shows the geographic impact of Earl F. Walborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Earl F. Walborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Earl F. Walborg more than expected).
Fields of papers citing papers by Earl F. Walborg
This network shows the impact of papers produced by Earl F. Walborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Earl F. Walborg. The network helps show where Earl F. Walborg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Earl F. Walborg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 55 | |
| 2 | 2006 | 40 | |
| 3 | 2005 | 1 | |
| 4 | 2004 | 136 | |
| 5 | 1999 | 4 | |
| 6 | 1999 | 33 | |
| 7 | 1998 | 429 | |
| 8 | 1998 | 16 | |
| 9 | 1998 | 55 | |
| 10 | 1996 | 5 | |
| 11 | 1996 | 25 | |
| 12 | 1996 | 26 | |
| 13 | 1995 | 32 | |
| 14 | Hepatic effects of dieldrin and phenobarbital in male B6C3F1 mice and Fisher 344 rats: species selective induction of DNA synthesis. | 1995 | 5 |
| 15 | Characterization of a family of glycoproteins associated with the bile canalicular membrane of normal hepatocytes but not expressed by two transplantable rat hepatocellular carcinomas. | 1983 | 40 |
| 16 | 1979 | 5 | |
| 17 | 1979 | 11 | |
| 18 | 1977 | 3 | |
| 19 | 1975 | 23 | |
| 20 | 1969 | 25 |
About Earl F. Walborg
Earl F. Walborg is a scholar working on Biotechnology, Nutrition and Dietetics and Cancer Research, having authored 62 papers that have together received 2.0k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (23 papers), Carcinogens and Genotoxicity Assessment (7 papers), Microbial Metabolites in Food Biotechnology (6 papers), Carbohydrate Chemistry and Synthesis (6 papers), RNA and protein synthesis mechanisms (5 papers), Toxin Mechanisms and Immunotoxins (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Enzyme Production and Characterization (3 papers). The work is most often cited by research in Cancer Research (321 citations), Molecular Biology (1.1k citations) and Pharmacology (125 citations). Earl F. Walborg has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include James E. Klaunig, Kyle L. Kolaja, S Bachowski, Donald E. Stevenson, D.E. Stevenson, Darrell N. Ward, Yawei Xu, Jeffrey S. Isenberg, Yong Xu and Douglas C. Hixson. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.